FDA 510(k)

AllerBlock Junior

K号: K201734 · 2021-03-26

决定日期2021-03-26

产品代码NUP

咨询委员会医疗设备监管文本翻译如下： HO 请注意，由于您没有提供具体的医疗设备监管文本内容，以上仅为示例。请提供具体的文本内容以便进行准确的翻译。

决定实质等同

器械摘要

AllerBlock Junior is the device name listed in this FDA 510(k) record. The listed applicant is Nasaleze International, Ltd.. It received FDA 510(k) clearance on 2021-03-26 under 510(k) number K201734. The device is classified under product code NUP. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the AllerBlock Junior?

AllerBlock Junior is a medical device that received FDA 510(k) clearance on 2021-03-26. The listed applicant is Nasaleze International, Ltd.. The 510(k) number is K201734.

When did AllerBlock Junior receive FDA 510(k) clearance?

AllerBlock Junior received FDA 510(k) clearance on 2021-03-26, under 510(k) number K201734.

Who is the listed applicant for AllerBlock Junior?

The FDA 510(k) record lists Nasaleze International, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for AllerBlock Junior?

The FDA product code for AllerBlock Junior is NUP.

列明Nasaleze International, Ltd.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K170848Alzair 过敏阻断器

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。